StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance NASDAQ:TTNP opened at $6.88 on Wednesday. The firm has a market capitalization of $6.29 million, a price-to-earnings ratio of -0.84 and […]